FSCN1 and cancer: Furthermore, cytokines (IL-6 or tumor necrosis factor-alpha (TNF-α) trigger the NF-κB and STAT3 pathways, which are essential for enhancing FSCN1 expression in cancer [79,80,81] (Figure 1).